跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYRIMET - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
LYRIMET
Approved
STANDARD
LYRIMET
Bafna Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
14c05d63c604d6c0
Company
Bafna Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
14c05d63c604d6c0
Drug Approval Philippines Name
LYRIMET
Product Name
LYRIMET
Registration Number
DRP-13379
Brand Name
LYRIMET
Generic Name
PREGABALIN + METHYLCOBALAMIN
Dosage Form
Capsule
Dosage Strength
75mg/750mcg
Manufacturer
Bafna Pharmaceuticals Limited
Importer
Medethix Inc.
Distributor
Medethix Inc.
Issuance Date
25 August 2024
Expiry Date
08 February 2030
Pharmacologic Category
Antiepileptic/ Vitamin (Cyanocobalamin analogue)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
14c05d63c604d6c0
Type
Standard
Back to Philippines FDA Approvals